Most Recent Additions*
Lymph node metastases in young patients with gastrointestinal stromal tumor: A nationwide analysis
Andrew M. Fleming, Joshua Herb, Zachary E. Stiles, Laura Burkbauer, Paxton V. Dickson, Evan S. Glazer, David Shibata, Andrew J. Murphy, Andrew M. Davidoff, Elizabeth Gleeson, Hong J. Kim, Michael O. Meyers, Karyn Stitzenberg, David W. Ollila, and Jeremiah L. Deneve
Outcomes and predictors of survival for tracheal cancer
Nidhi Desai, Benjamin R. Zambetti, Denise L. Wong, Aubrey E. Schachter, Nathan P. Judge, Ganpat S. Valaulikar, and Thomas Ng
Introduction to human-machine interface
Shama Mujawar, Aarohi Deshpande, Aarohi Gherkar, Samson Eugin Simon, and Bhupendra Prajapati
The challenge of clinical end points in sickle cell disease
Kenneth I. Ataga
Amphiphilic small molecule antimicrobials: From cationic antimicrobial peptides (CAMPs) to mechanism-related, structurally-diverse antimicrobials
Jiani Yuan, Jiaxing Wang, Xiaoxue Li, Ya Zhang, Jinghong Xian, Chengdi Wang, Jifa Zhang, and Chengyong Wu
Communication with physicians and family about breast Cancer recurrence
Kimberly M. Kelly, Pragya Rai, Jamie L. Studts, Stephanie Dickinson, Beate Henschel, Mark Dignan, Mara Chambers, and Hannah Hazard-Jenkins
Triage of Emergent Large Vessel Occlusion (ELVO) patients directly to Comprehensive Stroke Centers (CSCs) is good practice and benefits patients in Urban and Suburban population Centers - New insights from the TRIAGE-STROKE and RACECAT studies
David Fiorella, Tudor G. Jovin, Adam S. Arthur, Raul Nogueira, Adnan H. Siddiqui, Joshua A. Hirsch, and Felipe C. Albuquerque
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity
Raymond S. Douglas, Steven Couch, Sara T. Wester, Brian T. Fowler, Catherine Y. Liu, Prem S. Subramanian, Rosa Tang, Quang T. Nguyen, Robi N. Maamari, Shoaib Ugradar, Kate Hsu, Michael Karon, and Marius N. Stan
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial
Ambarish Pandey, Ahmed A. Kolkailah, Francesco Cosentino, Christopher P. Cannon, Robert C. Frederich, David Z.I. Cherney, Samuel Dagogo-Jack, Richard E. Pratley, Nilo B. Cater, Ira Gantz, James P. Mancuso, and Darren K. McGuire
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype
Sarah Asemota, Wendy Effah, Kirsten L. Young, Jeremiah Holt, Linnea Cripe, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Dong Jin Hwang, Yali He, Keely Mcnamara, Daniel Johnson, Yinan Wang, Brandy Grimes, Yekta Khosrosereshki, and T. J. Hollingsworth
A Quantum Logic Gate in the DNA Deoxyribose Moiety
F. Matthew Mihelic
Emergent potential of the terahertz CMOS microprocessor
F. Matthew Mihelic
Perspective on the Utilization and the Outcome of Digital Tools to Manage Chronic Diseases
Narjodh Singh
Utilizing Stakeholder Input within the Tennessee Heart Health Network to Improve Cardiovascular Health Outcomes in Tennessee
Abigail C. Bennett
The Effects of Exosomal Derived TSG-6 on Microglia Activation
Jonathan A. Martinez and Rajashekhar Gangaraju MD
Medication-Assisted Therapy and First Episode Psychosis: Evaluating Treatment and Readmission Rates: A Scoping Review
Whitney Nichole Trotter MS, BSN, RDN/LDN, RN and Margaret Carrie Harvey PhD, APRN, ACNP-BC, CHFN
The NoLoCo Strategy for Essential Hypertension
F. Matthew Mihelic MD
Using preliminary data and prospective power analyses for mid-stream revision of projected group and subgroup sizes in pragmatic patient-centered outcomes research
Elizabeth A. Tolley MD, Satya Surbhi MD, and James E. Bailey MD
*Updated as of 03/28/24.